NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
01/29/2022
Back to search
Official data from USPTO
MEDI-DERM TOPICAL PAIN RELIEF CREAM
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
MEDI-DERM TOPICAL PAIN RELIEF CREAM
ST13
US500000085463260Class
5
Filing
85463260
Registration
4167526
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
01/29/2022
Classification
Registered
Trademark type
Word
Nice classes
5
Filing date
11/03/2011
Registration date
07/03/2012
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/29/2022
Last transaction
01/29/2022
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
05/01/2011
First use in commerce
05/01/2011
Drawing code
4
Owner type
16
Owner location
Fountain Hills, CA, US
Examiner
KLINE, MATTHEW
Law office
L30
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Two Hip Consulting & Sales, LLC
Two Hip Consulting & Sales, LLC
Representatives
Two Hip Consulting & Sales, LLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Preparation for the relief of pain
Publications
History of USPTO decisions and trademark events.
28 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
01/29/2022
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
01/29/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/29/2022
E89R
TEAS SECTION 8 & 9 RECEIVED
08/21/2021
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
07/03/2021
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
10/04/2017
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
10/04/2017
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
10/01/2017
PR23
POST REGISTRATION ACTION MAILED - SEC. 8 & 15
09/21/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/20/2017
E815
TEAS SECTION 8 & 15 RECEIVED
08/15/2017
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/15/2017
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
07/03/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
07/03/2012
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/17/2012
PUBO
PUBLISHED FOR OPPOSITION
04/17/2012
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/28/2012
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
03/10/2012
ALIE
ASSIGNED TO LIE
03/10/2012
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/23/2012
XAEC
EXAMINER'S AMENDMENT ENTERED
02/23/2012
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/23/2012
GNEA
EXAMINERS AMENDMENT E-MAILED
02/23/2012
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/23/2012
DOCK
ASSIGNED TO EXAMINER
02/22/2012
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/07/2011
NWAP
NEW APPLICATION ENTERED
11/07/2011
Continuous trademark protection
Get notified about every new filing that threatens MEDI-DERM TOPICAL PAIN RELIEF CREAM or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.